Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
Active, not recruiting · NCT02243605 · Registry updated 2026-08-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma | Ewing sarcoma, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma | Active, not recruiting | Phase 2 | 2026-08-18 | NCT02243605 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Center Claudius Regaud | Toulouse | France | 3 |
| Centre Antoine Lacassagne | Nice | France | 83 |
| Centre Georges-Francois Leclerc | Dijon | France | 5 |
| Centre Leon Berard | Lyon | France | 70 |
| Centre Oscar Lambert | Lille | France | 3 |
| CHRU Strasbourg - Hospital Civil | Strasbourg | France | 3 |
| Gustave Roussy | Villejuif | France | 119 |
| Hopital de la Timone | Marseille | France | 11 |
| Institut Bergonie Cancer Center | Bordeaux | France | 3 |
| Institut Curie Paris | Paris | France | 8 |
| Institut de Cancerologie de l'Ouest-Rene Gauducheau | Saint-Herblain | France | 2 |